Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis

Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis

US Patent 8034828 · Granted Oct 11, 2011

Estimated economic value: $22,035,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Contraceptive compositions with reduced adverse effects2025
Contraceptive methods with improved pearl index2025
Immunogenic compositions against S. aureus2020
Eye device2018
Eye device2018
Pyrazolonaphthyridinone derivatives as MetAP2 inhibitors (methionine aminopeptid2018
Estrogenic components for use in the treatment of neurological disorders2017
Combination treatment of cancer2017
Use of estetrol as emergency contraceptive2017
Estrogenic components for use in the treatment of neurological disorders2016
Substituted dimeric quinazoline-2,4-diones as FGF receptor agonists2015
Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof2015